These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38814825)

  • 1. Mice Hepatic Organoids for Modeling Nonalcoholic Fatty Liver Disease and Drug Response.
    Zhou Z; Zheng X; Xie M; Lin Z; Du F; Shi X; Li R
    Stem Cells Dev; 2024 Aug; 33(15-16):387-398. PubMed ID: 38814825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet.
    Lee MR; Park KI; Ma JY
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29295591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease.
    Qiao JT; Cui C; Qing L; Wang LS; He TY; Yan F; Liu FQ; Shen YH; Hou XG; Chen L
    Metabolism; 2018 Apr; 81():13-24. PubMed ID: 29106945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles.
    Hernández A; Geng Y; Sepúlveda R; Solís N; Torres J; Arab JP; Barrera F; Cabrera D; Moshage H; Arrese M
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165753. PubMed ID: 32126269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent changes and association between liver free fatty acids, serum lipid profile and histological features in mice model of nonalcoholic fatty liver disease.
    Stanković MN; Mladenović DR; Duričić I; Šobajić SS; Timić J; Jorgačević B; Aleksić V; Vučević DB; Ješić-Vukićević R; Radosavljević TS
    Arch Med Res; 2014 Feb; 45(2):116-24. PubMed ID: 24480733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
    Im AR; Kim YH; Lee HW; Song KH
    J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36.
    Shen C; Chen JH; Oh HR; Park JH
    FEBS Lett; 2021 Oct; 595(19):2493-2503. PubMed ID: 34536973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
    Liu X; Henkel AS; LeCuyer BE; Schipma MJ; Anderson KA; Green RM
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G965-74. PubMed ID: 26472223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
    Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
    Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
    Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
    Sendi H; Mead I; Wan M; Mehrab-Mohseni M; Koch K; Atala A; Bonkovsky HL; Bishop CE
    PLoS One; 2018; 13(7):e0200847. PubMed ID: 30024933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
    He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
    World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNAs Involved in Progression of Non-Alcoholic Fatty Liver Disease to Steatohepatitis.
    Atanasovska B; Rensen SS; Marsman G; Shiri-Sverdlov R; Withoff S; Kuipers F; Wijmenga C; van de Sluis B; Fu J
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
    Saeed WK; Jun DW; Jang K; Ahn SB; Oh JH; Chae YJ; Lee JS; Kang HT
    World J Gastroenterol; 2018 Dec; 24(48):5477-5490. PubMed ID: 30622377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
    Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System.
    Wang Y; Wang H; Deng P; Tao T; Liu H; Wu S; Chen W; Qin J
    ACS Biomater Sci Eng; 2020 Oct; 6(10):5734-5743. PubMed ID: 33320545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RORα contributes to the maintenance of genome ploidy in the liver of mice with diet-induced nonalcoholic steatohepatitis.
    Kim JY; Yang IS; Kim HJ; Yoon JY; Han YH; Seong JK; Lee MO
    Am J Physiol Endocrinol Metab; 2022 Feb; 322(2):E118-E131. PubMed ID: 34894722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.